The inflammasome: an emerging therapeutic oncotarget for cancer prevention
about
CD200Fc reduces LPS-induced IL-1β activation in human cervical cancer cells by modulating TLR4-NF-κB and NLRP3 inflammasome pathway.Inflammasome as a Therapeutic Target for Cancer Prevention and Treatment.Perfluorodecanoic acid stimulates NLRP3 inflammasome assembly in gastric cells.Copper or/and arsenic induce oxidative stress-cascaded, nuclear factor kappa B-dependent inflammation and immune imbalance, trigging heat shock response in the kidney of chicken.Inflammasome: A Double-Edged Sword in Liver Diseases
P2860
The inflammasome: an emerging therapeutic oncotarget for cancer prevention
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The inflammasome: an emerging therapeutic oncotarget for cancer prevention
@ast
The inflammasome: an emerging therapeutic oncotarget for cancer prevention
@en
The inflammasome: an emerging therapeutic oncotarget for cancer prevention
@nl
type
label
The inflammasome: an emerging therapeutic oncotarget for cancer prevention
@ast
The inflammasome: an emerging therapeutic oncotarget for cancer prevention
@en
The inflammasome: an emerging therapeutic oncotarget for cancer prevention
@nl
prefLabel
The inflammasome: an emerging therapeutic oncotarget for cancer prevention
@ast
The inflammasome: an emerging therapeutic oncotarget for cancer prevention
@en
The inflammasome: an emerging therapeutic oncotarget for cancer prevention
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
The inflammasome: an emerging therapeutic oncotarget for cancer prevention
@en
P2093
Cheng Peng
Mario D. Cordero
Pengxi Liu
Shaowen Zhong
Wang Zhiyu
P2860
P304
50766-50780
P3181
P356
10.18632/ONCOTARGET.9391
P407
P5008
P577
2016-08-02T00:00:00Z